Large Animal Model of Macular Degeneration

黄斑变性大型动物模型

基本信息

项目摘要

DESCRIPTION (provided by applicant): The prime objective of this proposal is to produce a large animal model of macular degeneration using the gene ELOVL4. Transgenic pigs may be useful for the elucidation of the molecular mechanisms responsible for macular degeneration and for the development of therapeutic interventions. The pig's similarity to humans in size and retinal anatomy and physiology make it a logical choice for these experiments. Further, the production of transgenic pigs is a virtual surety. Only transgenic primates would provide a more accurate model, however, both the low supply of primates and low efficiency of these procedures will likely prevent gone transfer being a routine procedure in primates. Using a positional cloning approach, one of us (Zhang) has identified a disease gene called ELOVL4, which is responsible for an autosomal dominant form of Stargardt's-like macular dystrophy (STGD3) and autosomal dominant macular dystrophy (adMD). STGD3 and adMD are two related forms of inherited macular degeneration characterized by decreased visual acuity, macular atrophy, and fundus flecks. A single five base-pair deletion in the coding region of ELOVL4 is found in all affected members of four independent STGD3 families and one adMD family. The deletion generates a frame-shift mutation and results in loss of 51 amino acids at the C-terminus including a putative di-lysine ER targeting signal. ELOVL4 demonstrated cone and rod photoreceptor specific expression in the eye and encoded a putative transmembrane protein with similarities to the ELO family of proteins involved in elongation of very long chain fatty acids. Stargardt's macular dystrophy is the most common juvenile macular degeneration and shares many important clinical and histopathological similarities with AMD including an abnormal accumulation of lipofuscin in the RPE, atrophy of the RPE and overlying photoreceptor cells, and loss of central vision. ELOVL4 is the first gene involved in the biosynthesis of long chain fatty acids implicated in any form of photoreceptor degeneration. Studies of pigs transgenic for ELOVL4 should lead to new insights into lipid metabolism in photoreceptor cells and may reveal a novel pathway in the pathogenesis of macular degeneration.
描述(由申请人提供):本提案的主要目的是使用基因DLVL 4产生黄斑变性的大型动物模型。转基因猪可能有助于阐明黄斑变性的分子机制和开发治疗干预措施。猪在大小和视网膜解剖学和生理学上与人类相似,这使其成为这些实验的合理选择。此外,转基因猪的生产是一个虚拟的支持。只有转基因灵长类动物才能提供更准确的模型,然而,灵长类动物的低供应和这些程序的低效率可能会阻止基因转移成为灵长类动物的常规程序。 使用定位克隆方法,我们中的一个(Zhang)已经确定了一个名为p53 VL4的疾病基因,该基因负责常染色体显性形式的Stargardt样黄斑营养不良(STGD 3)和常染色体显性黄斑营养不良(adMD)。STGD 3和adMD是两种相关形式的遗传性黄斑变性,其特征在于视力下降、黄斑萎缩和眼底颤动。在4个独立的STGD 3家族和1个adMD家族的所有受影响的成员中发现了一个单独的5个碱基对的缺失。该缺失产生移码突变,并导致C末端51个氨基酸的缺失,包括推定的二赖氨酸ER靶向信号。HPVL4在眼睛中表现出视锥和视杆光感受器特异性表达,并编码一种推定的跨膜蛋白,其与参与极长链脂肪酸延伸的ELO蛋白家族相似。 Stargardt黄斑营养不良是最常见的青少年黄斑变性,并且与AMD具有许多重要的临床和组织病理学相似性,包括RPE中脂褐质的异常积累、RPE和覆盖的感光细胞的萎缩以及中心视力的丧失。HPVL4是第一个参与长链脂肪酸生物合成的基因,该脂肪酸与任何形式的光感受器变性有关。转基因猪的研究将导致对感光细胞脂质代谢的新见解,并可能揭示黄斑变性发病机制的新途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert M Petters其他文献

Robert M Petters的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert M Petters', 18)}}的其他基金

CTRP Transgenics and Knockouts as Models of Macular Degeneration
CTRP 转基因和基因敲除作为黄斑变性模型
  • 批准号:
    7494006
  • 财政年份:
    2007
  • 资助金额:
    $ 14.65万
  • 项目类别:
CTRP Transgenics and Knockouts as Models of Macular Degeneration
CTRP 转基因和基因敲除作为黄斑变性模型
  • 批准号:
    7296791
  • 财政年份:
    2007
  • 资助金额:
    $ 14.65万
  • 项目类别:
Large Animal Model of Macular Degeneration
黄斑变性大型动物模型
  • 批准号:
    6894004
  • 财政年份:
    2003
  • 资助金额:
    $ 14.65万
  • 项目类别:
Large Animal Model of Macular Degeneration
黄斑变性大型动物模型
  • 批准号:
    6611739
  • 财政年份:
    2003
  • 资助金额:
    $ 14.65万
  • 项目类别:
GENETIC MODEL OF EYE DISEASE
眼部疾病的遗传模型
  • 批准号:
    3267101
  • 财政年份:
    1992
  • 资助金额:
    $ 14.65万
  • 项目类别:
GENETIC MODEL OF EYE DISEASE
眼部疾病的遗传模型
  • 批准号:
    2331656
  • 财政年份:
    1992
  • 资助金额:
    $ 14.65万
  • 项目类别:
GENETIC MODEL OF EYE DISEASE
眼部疾病的遗传模型
  • 批准号:
    3267102
  • 财政年份:
    1992
  • 资助金额:
    $ 14.65万
  • 项目类别:
GENETIC MODEL OF EYE DISEASE
眼部疾病的遗传模型
  • 批准号:
    2163453
  • 财政年份:
    1992
  • 资助金额:
    $ 14.65万
  • 项目类别:
DEVELOPMENT OF RAT AND PORCINE EMBRYOS IN VITRO
大鼠和猪胚胎的体外发育
  • 批准号:
    3552510
  • 财政年份:
    1986
  • 资助金额:
    $ 14.65万
  • 项目类别:
DEVELOPMENT OF RAT AND PORCINE EMBRYOS IN VITRO
大鼠和猪胚胎的体外发育
  • 批准号:
    3552508
  • 财政年份:
    1986
  • 资助金额:
    $ 14.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了